A 12-immune cell signature to predict relapse and guide chemotherapy for stage II colorectal cancer

The management of stage II colorectal cancer is still difficult. We aimed to construct a new immune cell-associated signature for prognostic evaluation and guiding chemotherapy in stage II colorectal cancer. We used the “Cell Type Identification by Estimating Relative Subsets of RNA Transcripts” (CI...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Xianglong, Zhu, Xiaoqiang, Meng, Wenying, Bai, Shiguang, Shi, Min, Xiang, Shihao, Zhao, Chen, Wang, Yugang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585080/
https://www.ncbi.nlm.nih.gov/pubmed/32855365
http://dx.doi.org/10.18632/aging.103707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585080/
https://www.ncbi.nlm.nih.gov/pubmed/32855365
http://dx.doi.org/10.18632/aging.103707

Ejemplares similares